The Boston Globe has taken a detailed look at the catalog of decisions that let to the fungal meningitis outbreak earlier this year. And the piece sheds some light on how compounding pharmacies stepped in to fill gaps left by shortages of drugs from manufacturers. "[Hospitals] were freaking out. If they couldn't get these drugs, patients were going to die," an anonymous former New England Compounding Center salesman said. Article